Skip to main content
Year archive

ERYTECH Pharma S.A. — 2021 filings

All 118 regulatory filings released by ERYTECH Pharma S.A. (ERYP) in 2021, sourced directly from the official regulator.

118 Filings
2021 Period
2021 filings (118)
Filing Released Lang
Franchissement de seuils
Declaration of Voting Results & Voting Rights Announcements
2021-12-28 French
Franchissement de seuils
Major Shareholding Notification
2021-12-24 French
ERYTECH annonce la levée de 7,85 millions de dollars dans le cadre d’une Registered Offering
Capital/Financing Update
2021-12-14 French
ERYTECH Announces $7.85 Million Registered Direct Offering
Capital/Financing Update
2021-12-14 English
ERYTECH annonce la présentation des résultats du programme d’accès élargi dans la LAL lors du congrès annuel de l’ASH 2021 et l’acceptation de deux abstracts à l’ASCO-GI
Regulatory Filings
2021-12-13 French
ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI
Regulatory Filings
2021-12-13 English
Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-10 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-10 French
ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors
Investor Presentation
2021-11-29 English
ERYTECH obtient un brevet aux Etats-Unis pour l’utilisation de la méthioninase suivie de l’asparaginase dans le traitement des tumeurs solides
Regulatory Filings
2021-11-29 French
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021
Earnings Release Q3 2021
2021-11-15 English
ERYTECH fait le point sur ses activités et publie ses résultats du troisième trimestre 2021
Earnings Release Q3 2021
2021-11-15 French
ERYTECH annonce la présentation d’un poster lors du congrès annuel 2021 de l'American Society of Hematology
Report Publication Announcement
2021-11-15 French
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting
Regulatory Filings
2021-11-15 English
ERYTECH annonce la publication d'un article sur la caractérisation des globules rouges dans un journal à facteur d'impact élevé
Regulatory Filings
2021-11-10 French
ERYTECH Announces Publication of a Paper on Red-Blood Cell Characterization in High Impact Peer Reviewed Journal
Regulatory Filings
2021-11-10 English
ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare Conference
Regulatory Filings
2021-11-09 English
ERYTECH présentera à l’occasion de la 12ème Conférence Jefferies Global London Healthcare
Regulatory Filings
2021-11-09 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 octobre 2021
Share Issue/Capital Change
2021-11-05 French
Monthly information related to total number of voting rights and shares composing the share capital – October 30, 2021
Regulatory Filings
2021-11-05 English
ERYTECH annonce les résultats de l’étude de phase 3 TRYbeCA-1 évaluant eryaspase comme traitement de seconde ligne chez des patients atteints d’un cancer avancé du pancréas
Earnings Release FY 2021
2021-10-25 French
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer
Earnings Release FY 2021
2021-10-25 English
Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2021.
Declaration of Voting Results & Voting Rights Announcements
2021-10-07 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Septembre 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-07 French
ERYTECH annonce la détermination de la Dose Maximale Tolérée dans le cadre de l’essai de Phase 1 mené par un investigateur avec eryaspase dans le traitement en première ligne du cancer du pancréas
Earnings Release FY 2021
2021-10-04 French
ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Regulatory Filings
2021-10-04 English
ERYTECH participera à la conférence HealthTech Innovation Days (HTID) organisée par France Biotech
Investor Presentation
2021-09-28 French
ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech
Regulatory Filings
2021-09-28 English
ERYTECH annonce la mise à disposition de son rapport financier semestriel 2021
Report Publication Announcement
2021-09-22 French
ERYTECH Announces the Availability of its Half-Year Financial Report 2021
Report Publication Announcement
2021-09-22 English
Rapport financier semestriel 2021
Interim / Quarterly Report H1 2021
2021-09-21 French
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2021
Interim / Quarterly Report H2 2021
2021-09-20 French
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021
Interim / Quarterly Report H2 2021
2021-09-20 English
ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update
Report Publication Announcement
2021-09-15 English
ERYTECH tiendra un webcast le 21 septembre 2021 à l’occasion de ses résultats semestriels 2021
Report Publication Announcement
2021-09-15 French
ERYTECH tiendra une présentation à la H.C. Wainwright 23rd Annual Global Investment Conference
Report Publication Announcement
2021-09-06 French
ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Investor Presentation
2021-09-06 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 août 2021
Share Issue/Capital Change
2021-09-03 French
Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2021
Regulatory Filings
2021-09-03 English
ERYTECH organise un webinaire, sur eryaspase dans le cancer du pancréas, avec des leaders d'opinion
Report Publication Announcement
2021-08-24 French
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
Report Publication Announcement
2021-08-24 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 juillet 2021
Share Issue/Capital Change
2021-08-05 French
Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021
Regulatory Filings
2021-08-05 English
ERYTECH to Participate in the BTIG Virtual Biotechnology Conference
Regulatory Filings
2021-07-27 English
ERYTECH annonce sa participation à la conférence virtuelle BTIG Biotechnology
Regulatory Filings
2021-07-27 French
ERYTECH confirme son intention de déposer une demande de BLA pour eryaspase dans le traitement des patients atteints de LAL hypersensible
Regulatory Filings
2021-07-21 French
ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients
Regulatory Filings
2021-07-21 English
Franchissement de seuil
Major Shareholding Notification
2021-07-19 French
Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2021
Share Issue/Capital Change
2021-07-06 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Juin 2021
Share Issue/Capital Change
2021-07-06 French
COMPTE RENDU - ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021
AGM Information
2021-06-25 French
Report - Erytech’s Combined Shareholders’ Meeting on June 25, 2021
AGM Information
2021-06-25 English
Franchissements de seuils
Major Shareholding Notification
2021-06-09 French
Franchissement de seuil
Major Shareholding Notification
2021-06-09 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Mai 2021
Regulatory Filings
2021-06-07 French
Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-07 English
ERYTECH participera aux prochaines conférences virtuelles des investisseurs en juin
Investor Presentation
2021-05-26 French
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
Investor Presentation
2021-05-26 English
ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021
AGM Information
2021-05-25 French
Erytech’s Combined Shareholders’ Meeting on June 25, 2021
AGM Information
2021-05-25 English
Franchissements de seuils
Major Shareholding Notification
2021-05-19 French
Franchissement de seuils
Major Shareholding Notification
2021-05-17 French
Franchissement de seuils
Major Shareholding Notification
2021-05-12 French
Franchissement de seuils et déclaration d'intention
Director's Dealing
2021-05-11 French
Franchissements de seuils et déclaration d'intention
Director's Dealing
2021-05-10 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2021
Share Issue/Capital Change
2021-05-07 French
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2021
Share Issue/Capital Change
2021-05-07 English
Franchissement de seuil
Major Shareholding Notification
2021-05-06 French
Franchissement de seuils
Major Shareholding Notification
2021-05-05 French
ERYTECH fait le point sur ses activités et publie ses résultats financiers du premier trimestre 2021
Interim / Quarterly Report Q1 2021
2021-05-04 French
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021
Interim / Quarterly Report Q1 2021
2021-05-04 English
ERYTECH Announces $30.0 Million Registered Direct Offering
Share Issue/Capital Change
2021-04-29 English
ERYTECH annonce la levée de 30 millions de dollars dans le cadre d’une registered offering
Share Issue/Capital Change
2021-04-29 French
ERYTECH annonce sa position de trésorerie au 31 mars 2021 et les détails de participation au webcast de présentation des résultats du T1 2021
Earnings Release Q1 2021
2021-04-29 French
ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 conference call
Report Publication Announcement
2021-04-29 English
ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL
Regulatory Filings
2021-04-20 English
ERYTECH sollicite une réunion auprès de la FDA en amont de sa demande de BLA afin d’évaluer une voie d’approbation dans la LAL
Regulatory Filings
2021-04-20 French
ERYTECH annonce la fin du recrutement de la première cohorte de son étude de Phase 1 conduite par un investigateur avec eryaspase dans le traitement de première ligne du cancer du pancréas
Earnings Release FY 2021
2021-04-19 French
ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Earnings Release FY 2021
2021-04-19 English
Franchissement de seuil
Major Shareholding Notification
2021-04-16 French
Franchissement de seuil
Major Shareholding Notification
2021-04-12 French
ERYTECH annonce sa participation à des conférences investisseurs virtuelles en avril
Regulatory Filings
2021-04-07 French
ERYTECH to Participate in Upcoming Virtual Investor Conferences in April
Regulatory Filings
2021-04-07 English
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2021
Regulatory Filings
2021-04-07 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2021
Share Issue/Capital Change
2021-04-07 French
Franchissement de seuil
Declaration of Voting Results & Voting Rights Announcements
2021-04-01 French
Franchissement de seuil
Major Shareholding Notification
2021-03-15 French
ERYTECH annonce le dépôt de son Document d’Enregistrement Universel 2020 et de son Form 20-F 2020
Report Publication Announcement
2021-03-09 French
ERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
Report Publication Announcement
2021-03-09 English
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
Earnings Release FY 2020
2021-03-08 English
ERYTECH fait le point sur ses activités et publie ses résultats financiers de l’exercice 2020
Earnings Release FY 2020
2021-03-08 French
Document d'Enregistrement Universel 2020
Annual Report FY 2020
2021-03-08 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2021
Share Issue/Capital Change
2021-03-05 French
Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2021
Share Issue/Capital Change
2021-03-05 English
ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update
Report Publication Announcement
2021-03-04 English
ERYTECH tiendra un webcast le 9 mars 2021 à l’occasion de ses résultats annuels 2020
Report Publication Announcement
2021-03-04 French
ERYTECH annonce sa participation à des conférences investisseurs virtuelles en mars
Report Publication Announcement
2021-02-24 French
ERYTECH to Participate in Upcoming Virtual Investor Conferences in March
Investor Presentation
2021-02-24 English
ERYTECH tiendra une présentation à l’occasion du BIO CEO & Investor Conference 2021
Regulatory Filings
2021-02-10 French
ERYTECH to Present at the 2021 BIO CEO & Investor Conference
Report Publication Announcement
2021-02-10 English
ERYTECH annonce la poursuite de son étude de Phase 3 TRYbeCA-1 dans le traitement en seconde ligne du cancer du pancréas jusqu’à l’analyse finale
Legal Proceedings Report
2021-02-08 French
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
Regulatory Filings
2021-02-08 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Janvier 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-04 French
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-04 English
Franchissement de seuil
Major Shareholding Notification
2021-02-03 French
ERYTECH Highlights 2021 Milestones and Provides Update on Cash Position
Earnings Release FY 2020
2021-01-25 English
ERYTECH rappelle les principales échéances cliniques attendues en 2021 et publie sa position de trésorerie à fin décembre 2020
Earnings Release FY 2020
2021-01-25 French
ERYTECH annonce le recrutement du premier patient dans une étude de phase 1 conduite par un investigateur avec eryaspase dans le traitement de première ligne du cancer du pancréas
Regulatory Filings
2021-01-14 French
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Regulatory Filings
2021-01-14 English
Franchissement de seuil
Major Shareholding Notification
2021-01-12 French
Franchissement de seuil
Major Shareholding Notification
2021-01-07 French
Franchissement de seuil
Major Shareholding Notification
2021-01-07 French
ERYTECH tiendra une présentation à l’occasion de la conférence virtuelle H.C. Wainwright BioConnect 2021
Investor Presentation
2021-01-06 French
ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
Report Publication Announcement
2021-01-06 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2020
Declaration of Voting Results & Voting Rights Announcements
2021-01-06 French
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2020
Declaration of Voting Results & Voting Rights Announcements
2021-01-06 English
ERYTECH tiendra une présentation lors de la 10ème édition du LifeSci Partners Healthcare Corporate Access
Report Publication Announcement
2021-01-04 French
ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
Report Publication Announcement
2021-01-04 English